EEF2K
Basic information
Region (hg38): 16:22206278-22288738
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (127 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EEF2K gene is commonly pathogenic or not. These statistics are base on transcript: NM_000013302.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 126 | 127 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 126 | 2 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| EEF2K | protein_coding | protein_coding | ENST00000263026 | 17 | 80952 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.36e-20 | 0.0532 | 125477 | 0 | 270 | 125747 | 0.00107 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.613 | 432 | 469 | 0.920 | 0.0000303 | 4801 |
| Missense in Polyphen | 136 | 170.38 | 0.7982 | 1746 | ||
| Synonymous | 0.326 | 193 | 199 | 0.971 | 0.0000147 | 1347 |
| Loss of Function | 1.13 | 34 | 41.9 | 0.812 | 0.00000239 | 432 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00190 | 0.00190 |
| Ashkenazi Jewish | 0.00199 | 0.00199 |
| East Asian | 0.000330 | 0.000326 |
| Finnish | 0.000370 | 0.000370 |
| European (Non-Finnish) | 0.00143 | 0.00143 |
| Middle Eastern | 0.000330 | 0.000326 |
| South Asian | 0.000492 | 0.000490 |
| Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced. {ECO:0000269|PubMed:14709557, ECO:0000269|PubMed:9144159}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Translation Factors;AMP-activated Protein Kinase (AMPK) Signaling;BDNF-TrkB Signaling;Signal Transduction;mTORC1-mediated signalling;mTOR signalling;mTOR signaling pathway;Signaling mediated by p38-gamma and p38-delta
(Consensus)
Recessive Scores
- pRec
- 0.174
Intolerance Scores
- loftool
- 0.917
- rvis_EVS
- -1.48
- rvis_percentile_EVS
- 3.7
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.977
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eef2k
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype;
Gene ontology
- Biological process
- response to ischemia;translational elongation;regulation of protein autophosphorylation;cellular response to insulin stimulus;negative regulation of apoptotic process;positive regulation of endocytosis;protein autophosphorylation;positive regulation of synapse assembly;positive regulation of dendritic spine morphogenesis;cellular response to calcium ion;cellular response to cAMP;cellular response to anoxia;cellular response to brain-derived neurotrophic factor stimulus;response to prolactin
- Cellular component
- cytoplasm;cytosol;postsynaptic density;dendritic spine
- Molecular function
- protein kinase activity;elongation factor-2 kinase activity;calcium ion binding;calmodulin binding;ATP binding;translation factor activity, RNA binding